Ageing, Cellular Senescence and Neurodegenerative Disease
Open accessThe DOI matches its Crossref record; 374 of the 385 references it cites were found in a registry or an index; 63 of the 277 sources its claims cite were checked for support.
Abstract
Ageing is a major risk factor for developing many neurodegenerative diseases. Cellular senescence is a homeostatic biological process that has a key role in driving ageing. There is evidence that senescent cells accumulate in the nervous system with ageing and neurodegenerative disease and may predispose a person to the appearance of a neurodegenerative condition or may aggravate its course. Research into senescence has long been hindered by its variable and cell-type specific features and the lack of a universal marker to unequivocally detect senescent cells. Recent advances in senescence markers and genetically modified animal models have boosted our knowledge on the role of cellular senescence in ageing and age-related disease. The aim now is to fully elucidate its role in neurodegeneration in order to efficiently and safely exploit cellular senescence as a therapeutic target. Here, we review evidence of cellular senescence in neurons and glial cells and we discuss its putative role in Alzheimer’s disease, Parkinson’s disease and multiple sclerosis and we provide, for the first time, evidence of senescence in neurons and glia in multiple sclerosis, using the novel GL13 lipofuscin stain as a marker of cellular senescence.
Overview
CoChat Summary
TL;DR
This review argues that cellular senescence contributes to ageing and neurodegenerative disease, with senescent cells accumulating in the nervous system and potentially influencing disease susceptibility, onset, and progression. It also reports novel GL13 lipofuscin evidence of senescent glia and neurons in secondary progressive multiple sclerosis lesions.
Key findings
- Cellular senescence is a homeostatic response triggered by irreparable DNA damage; senescent cells increase with ageing and are implicated in Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. The review states a primary causative role in neurodegeneration is unlikely, but senescence may contribute to susceptibility, age at presentation, and rate of progression.
- Senescence-like features are reported across CNS cell types, including astrocytes, microglia, oligodendrocytes, oligodendrocyte progenitor cells, neurons, and neural stem cells. In aged mice, about 20–80% of mature neurons exhibit a senescence-like phenotype; oligodendrocyte progenitor cells constitute approximately 3–10% of glial cells; brain volume loss may amount to up to 0.4% annually.
- Disease-specific evidence includes elevated p16INK4a mRNA in PD brain, increased SA-β-gal in CSF from PD patients, and elevated SASP-related cytokines in AD and PD. However, a meta-analysis showed no difference in telomere length between PD patients and age-matched controls, and AD telomere findings remain inconclusive.
- Novel MS findings: GL13 lipofuscin histochemistry detected lipofuscin+ glial cells in acute active and chronic active demyelinated white matter lesions from SP-MS cases, sparse cells in chronic inactive lesions, none in normal appearing white matter, and granular lipofuscin deposits in numerous neurons in subpial demyelinated cortical lesions and normal appearing cortex.
Methods
- Narrative review of cellular senescence in ageing and neurodegeneration, focusing on Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis.
- For the new MS evidence, the authors used GL13 (SenTraGor) lipofuscin histochemistry as a senescence marker on MS white matter lesions, normal appearing white matter, and cortical lesions; they also cite cuprizone-induced demyelination model data with correlation analysis between senescent glial cell number and demyelination/motor performance.
- No systematic review, meta-analysis, or primary sample size/statistical methods are stated for the MS histochemistry.
Limitations
- Stated: evidence connecting cellular senescence with mechanisms of neurodegeneration remains indirect and further investigation is required.
- Stated: the MS findings merit further quantitative investigation to differentiate ageing effects from MS and to associate senescence extent with other pathological and clinical parameters.
- Stated: no universal specific senescence marker exists and no consensus on optimal marker combination; senescence features are variable and cell-type specific. Evident: as a narrative review, it does not provide systematic search/quality assessment, and the primary MS histochemistry sample details are not reported.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Lipofuscin accumulation as a marker of cellular senescence in multiple sclerosis lesions. Demyelinated lesions were identified with myelin basic protein (MBP) immunohistochemistry and were staged according to Trapp et al. (1998) [287] as acute active, chronic active or chronic inactive using human leukocyte antigen-DR isotype (HLA-DR) immunohistochemistry on serial sections from paraffin embedded postmortem tissue blocks. Lipofuscin was detected with the GL13 hybrid histochemistry-immunohistochemistry method [58]. Acute active demyelinated white matter lesion with MBP staining showing ongoing perivascular demyelination in subcortical white matter from the parietal lobe of a 73-year-old secondary progressive multiple sclerosis (SP-MS) patient (MS51) (A(i)). Infiltration with HLA-DR+ cells with macrophage morphology throughout the demyelinated parenchyma (HLA DR immunohistochemistry) (A(ii)). Perivascular infiltration with CD8+ lymphocytes (CD8 immunohistochemistry) (A(iii)). GL13 staining in acute active lesions showed lipofuscin+ cells. Although many of them were perivascularly localized, some were not, suggesting that at least some of them maybe glial cells rather than inflammatory cells (A(iv)). Chronic actively demyelinating perivenentricular white matter lesion with a fully demyelinated lesion center (lack of MBP immunoreactivity) from a 74-year-old female MS patient (MS265) (B(i)). Typically, HLA-DR immunohistochemistry of serial sections exhibited a border infiltrated by numerous macrophages whereas the lesion centre is infiltrated by ramified microglia (B(ii)). Few CD8+ lymphocytes are present perivascularly (CD8 immunohistochemistry) (B(iii)). Lipofuscin+ cells with granular staining were found in the macrophage infiltrated lesion border (B(iv)). Chronic inactive subcortical white matter demyelinated lesion (lack of MBP immunoreactivity with a well demarcated border) from the left parietal lobe of a 71-year-old female SP-MS patient (MS33) (C(i)). Ramified microglial morphology throughout the demyelinated lesion area and lesion border (HLA-DR immunohistochemistry) typical of a chronic inactive lesion (C(ii)). Decreased axonal density in the demyelinated lesion seen with 200 KDa neurofilament immunohistochemistry (C(iii)). Numerous parenchymal lipofuscin+ cells in the demyelinated white matter. Lack of HLA-DR+ macrophages from the chronic demyelinated lesion suggests that the lipofuscin+ cells are glial (C(iv)). Subpial cortical demyelination (lack of MBP immunoreactivity extending from the pial surface into the deeper cortical layers from the parietal cortex of a 71-year-old female SP-MS patient (MS33) (D(i)). HLA-DR+ ramified microglia in the demyelinated cortical lesion (D(ii)) and few CD8+ lymphocytes infiltrating the adjacent pia matter (D(iii)). Lipofuscin+ cells mostly with neuronal morphology (inset) throughout the demyelinated cortex (D(iv)). Normal appearing cortex with intact appearing cortical myelin (MBP immunohistochemistry) from the left parietal lobe of a 71-year-old female SP-MS patient (MS33) (E(i)), HLA-DR immunoreactivity revealing quiescent ramified microglia (E(ii)) and normal-appearing axonal staining with 200 kDa neurofilament immunohistochemistry on a serial section (E(iii)). GL13 staining showed numerous lipofuscin+ cells mostly with neuronal morphology (E(iv)). Scale bars represent 500 μm (A(i),A(ii),B(i),B(ii),C(i),C(ii),C(iii),D(i),D(ii),E(i),E(ii)), 50 μm (D(iii),E(iii)) or 25 μm (A(iii),A(iv), B(iii), B(iv), C(iv), D(iv), E(iv)).](https://figures.cochat.ai/paper-figures/6bbbad0f51864a21a639dec131aee479/ageing-cellular-senescence-and-neurodegenerative-disease-figure-1.jpg)
Verification
Claims the paper makes
34 Valid · 2 Not valid · 116 Not checked · 33 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Age is the strongest predictor for the transition from the relapsing phase of MS, which is primarily inflammatory to the secondary progressive phase of the disease, which is thought to be mainly neurodegenerative [10,11].”
§ Ageing, Cellular Senescence and Neurodegenerative Disease > 1. Ageing and Neurodegeneration
What the sources say
- Not checked yetcites [10] Trapp B.D. Nave K.-A. Multiple Sclerosis: An Immune or Neurodegenerative Disorder? Annu. Rev. Neurosci. 2008 31 247 269 10.1146/annurev.neuro.30.051606.094313 18558855 source
- Partly supportedcites [11] Scalfari A. Neuhaus A. Daumer M. Ebers G.C. Muraro P.A. Age and disability accumulation in multiple sclerosis Neurology 2011 77 1246 1252 10.1212/WNL.0b013e318230a17d 21917763 PMC3179646 sourceExperimental — accuracy not yet measured
The Age at disease onset section reports that older age at relapsing-remitting onset increases the probability of conversion to secondary progressive MS. The Multiple analysis section finds an age effect independent of early relapse frequency, but does not establish age as the strongest predictor. Page numbers are not available in our copy. (LLM, conf=0.84)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Incidence of Parkinson’s disease (PD), the second most common age-related neurodegenerative condition also increases with age [8,9].”
§ Ageing, Cellular Senescence and Neurodegenerative Disease > 1. Ageing and Neurodegeneration
What the sources say
- Not checked yetcites [8] Blin P. Dureau-Pournin C. Foubert-Samier A. Grolleau A. Corbillon E. Jové J. Lassalle R. Robinson P. Poutignat N. Droz-Perroteau C. Moore N. Parkinson’s disease incidence and prevalence assessment in France using the national healthcare insurance database Eur. J. Neurol. 2015 22 464 471 10.1111/ene.12592 25389031 source
- Supportedcites [9] Duncan G.W. Khoo T.K. Coleman S.Y. Brayne C. Yarnall A.J. O’Brien J.T. Barker R.A. Burn D.J. The incidence of Parkinson’s disease in the North-East of England Age Ageing 2014 43 257 263 10.1093/ageing/aft091 23880142 source
The Key points section (p. 1 of that block) states outright 'The incidence of PD increases with age', and the Discussion reports that incidence 'peaked in the eighth decade' with 68% of new diagnoses aged over 70, backed by the age- and sex-specific crude rates in Table 2 (rising from 0.4 per 100 000 at 0-39 to 110.0 at 70-79). The Introduction also supports the framing that PD is 'the second most common neurodegenerative disorder after Alzheimer's disease'. The only caveat is the drop-off after 80, which the authors themselves flag as possibly reflecting under-ascertainment rather than a true decline. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Another key feature of cellular senescence is the senescence-associated secretory phenotype (SASP), which is dependent on p38MAPK (p38 mitogen-activated protein kinases), NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells), cGAS(cyclic GMP-AMP synthase)/STING(stimulator of IFN genes), NOTCH and mTORmammalian target of rapamycin) signalling [38,39,40,41,42].”
§ Ageing, Cellular Senescence and Neurodegenerative Disease > 3. The Senescence Phenotype
What the sources say
- Partly supportedcites [38] Baker D.J. Wijshake T. Tchkonia T. LeBrasseur N.K. Childs B.G. van de Sluis B. Kirkland J.L. van Deursen J.M. Clearance of p16Ink4a -positive senescent cells delays ageing- associated disorders Nature 2012 479 232 236 10.1038/nature10600 22048312 PMC3468323 sourceExperimental — accuracy not yet measured
The paper’s concluding discussion describes the senescence-associated secretory phenotype (SASP) as enabling secretion of growth factors, cytokines and proteases. It does not address whether SASP depends on p38MAPK, NF-κB, cGAS/STING, NOTCH or mTOR signalling (pages unavailable in our copy). (LLM, conf=0.85)
- Not checked yetcites [39] Krenning L. Feringa F.M. Shaltiel I.A. VandenBerg J. Medema R.H. Transient activation of p53 in G2 phase is sufficient to induce senescence Mol. Cell 2014 55 59 72 10.1016/j.molcel.2014.05.007 24910099 source
- Could not verifycites [40] Stein G.H. Drullinger L.F. Soulard A. Dulić V. Differential Roles for Cyclin-Dependent Kinase Inhibitors p21 and p16 in the Mechanisms of Senescence and Differentiation in Human Fibroblasts Mol. Cell. Biol. 1999 19 2109 2117 10.1128/MCB.19.3.2109 10022898 PMC84004 sourceExperimental — accuracy not yet measured
The Results and Discussion describe altered expression of extracellular-matrix-related genes in senescent fibroblasts, but do not address whether the senescence-associated secretory phenotype depends on the listed signalling pathways. Searches for SASP and for p38MAPK, NF-κB, cGAS/STING, NOTCH and mTOR found no passage establishing those dependencies. (LLM, conf=0.76)
- Could not verifycites [41] Sharma V. Gilhotra R. Dhingra D. Gilhotra N. Possible underlying influence of p38MAPK and NF-κB in the diminished anti-anxiety effect of diazepam in stressed mice J. Pharmacol. Sci. 2011 116 257 263 10.1254/jphs.11026FP 21720097 sourceExperimental — accuracy not yet measured
The Discussion addresses a possible p38MAPK–NF-κB relationship in immobilization-stress-induced anxiety in mice, not in cellular senescence. Searches for SASP, cellular senescence, cGAS/STING, NOTCH, and mTOR found no passage linking these pathways to the secretory phenotype. Page numbers were not available in our copy. (LLM, conf=0.78)
- Partly supportedcites [42] Yang H. Wang H. Ren J. Chen Q. Chen Z.J. cGAS is essential for cellular senescence Proc. Natl. Acad. Sci. USA 2017 114 E4612 E4620 10.1073/pnas.1705499114 28533362 PMC5468617 sourceExperimental — accuracy not yet measured
The Results report that cGAS deletion prevented induction of SASP genes after etoposide treatment, and the introductory text describes STING as a downstream component of cGAS signalling. But the paper does not establish that SASP depends on STING; the Discussion also raises STING-independent roles for cGAS. This citation supports the cGAS portion of the cited signalling claim, not its asserted STING dependence. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Altered mitochondrial function appears essential in mediating the senescence phenotype.”
§ Ageing, Cellular Senescence and Neurodegenerative Disease > 3. The Senescence Phenotype
What the sources say
- Partly supportedcites [60] Correia-Melo C. Marques F.D. Anderson R. Hewitt G. Hewitt R. Cole J. Carroll B.M. Miwa S. Birch J. Merz A. Mitochondria are required for pro-ageing features of the senescent phenotype EMBO J. 2016 35 724 742 10.15252/embj.201592862 26848154 PMC4818766 sourceExperimental — accuracy not yet measured
The Results report that mitochondrial depletion reduced multiple senescence markers and pro-inflammatory signals. The Discussion describes mitochondria as key to major ageing-promoting features, but says they are less important for proliferation arrest, which persisted after depletion. Thus the paper supports their role in major features, not their being essential to the entire senescence phenotype. (LLM, conf=0.84)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The ageing brain has higher background levels of low-grade inflammation primarily in the form of dystrophic microglia and increased levels pro-inflammatory cytokines and other mediators, a state known as inflammaging [100,101,102].”
§ Ageing, Cellular Senescence and Neurodegenerative Disease > 5. Cellular Senescence and Its Putative Role in Neurodegeneration
What the sources say
- Not checked yetcites [100] Streit W.J. Sammons N.W. Kuhns A.J. Sparks D.L. Dystrophic Microglia in the Aging Human Brain Glia 2004 45 208 212 10.1002/glia.10319 14730714 source
- Not checked yetcites [101] Rawji K.S. Mishra M.K. Michaels N.J. Rivest S. Stys P.K. Yong V.W. Immunosenescence of microglia and macrophages: Impact on the ageing central nervous system Brain 2016 139 653 661 10.1093/brain/awv395 26912633 PMC5839598 source
- Partly supportedcites [102] Olivieri F. Prattichizzo F. Grillari J. Balistreri C.R. Cellular Senescence and Inflammaging in Age-Related Diseases Med. Inflamm. 2018 2018 1 6 10.1155/2018/9076485 29849499 PMC5932453 sourceExperimental — accuracy not yet measured
In the main text (page unavailable), the paper defines inflammaging as chronic, systemic, low-grade inflammation and describes secretion of pro-inflammatory mediators. It also mentions a link between inflammaging and neurodegenerative diseases, but does not describe higher background inflammation specifically in the ageing brain or identify dystrophic microglia as its primary form. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
122 more claims · 25 with their cited sources checked
Create a free account to see all 185 claims and to verify the 214 references still open.
- Probably not a substantial claim. 12
- It may state two separate claims as one. 49
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Age‐related alterations in the brain microenvironment gradually led to increased BBB permeability and leakiness, neuronal degeneration, production of reactive oxygen species (ROS) and inflammation. 54 , 55 , 56”
From Therapeutic Properties and Pharmacological Activities of Asiaticoside and Madecassoside: A Review (2023) · cites this paper as [56]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The senescence stress response allows damaged cells to survive by upregulating senescent cell anti-apoptotic pathways (SCAPs)10 and causes inflammation through their senescence-associated secretory phenotype (SASP)11,12.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [11]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“TMAO is an amine oxide product of the bacterial metabolism that has been implicated in oxidative stress enhancement, BBB disruption, mitochondria dysfunction, brain aging and neurodegeneration [105,106,107]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [106]
Experimental — accuracy not yet measuredIn the citing paper
“Through dysregulation of p38 mitogen-activated protein kinases (p38MAPK), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), NOTCH, and mammalian target of rapamycin (mTOR) signaling, senescent cells can develop a senescence-associated secretory phenotype (SASP) (22, 23).”
From Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD): A Pilot Clinical Trial (2022) · cites this paper as [22]
In the citing paper
“Senescence of the central nervous system (CNS) drives many neurodegenerative diseases [55], including Alzheimer’s disease (AD), Parkinson’s disease (PD) and other types of dementia (Table 1).”
From Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases (2020) · cites this paper as [55]
Citations
Cites
1 retracted
Zheng, J., Son, D. J., Gu, S. M., Woo, J. R., Ham, Y. W., Lee, H. P., Kim, W. J., Jung, J. K., & Hong, J. T. (2016) · Scientific Reports · doi:10.1038/srep26357 · Cited by 92
RetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · cited 3×
“Genomic instability, telomere attrition, loss of proteostasis, dysregulated nutrient sensing, mitochondrial dysfunction, stem cell exhaustion, altered cellular communication and excessive cellular senescence have all been recognized as hallmarks of ageing [14].”
BackgroundThe serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508 · cited 1×
“According to the original observations by Hayflick and Moorhead (1961), when cultures of normal human fibroblasts were passaged serially they underwent stable cell cycle arrest that was accompanied by stereotypical phenotypic changes [21].”
MethodA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“0, which is measured using in situ staining with the chromogenic substrate X-gal [senescence-associated β-galactosidase activity (SA-β-gal)] is today the most widely used biomarker for detecting senescent cells [79,87].”
MethodThe amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · cited 1×
“Cognitive decline in AD is associated with the disseminated formation of extracellular amyloid plaques, intracellular neurofibrillary tangles comprising of hyperphosphorylated tau proteins, as well as neuronal and synaptic loss [183].”
BackgroundCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196 · cited 1×
“The astrocyte is the most abundant cell type of the CNS with a prominent role in the complex functions of the healthy CNS, as well as in various pathologies [136].”
Background
Research works printed but not linked: 2
- Ay M. Charli A. Jin H. Anantharam V. Kanthasamy A. Kanthasamy A.G. Quercetin Nutraceuticals Gupta R.C. Academic Press Boston, MA, USA 2016 447 452
- Schnekenburger M. Diederich M. Nutritional Epigenetic Regulators in the Field of Cancer: New Avenues for Chemopreventive Approaches Epigenetic Cancer Therapy Gray S.G. Academic Press Boston, MA, USA 2015 393 425
Cited by
Role of p53 in the Regulation of Cellular Senescence
Mijit, M., Caracciolo, V., Melillo, A., Amicarelli, F., & Giordano, A. (2020) · Biomolecules · doi:10.3390/biom10030420 · Cited by 639
“This form of senescence is also known as stress-induced premature senescence (SIPS) and has broad implications in health and diseases [8,9].”
BackgroundHou, Y., Wei, Y., Lautrup, S., Yang, B., Wang, Y., Cordonnier, S., Mattson, M. P., Croteau, D. L., & Bohr, V. A. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011226118 · Cited by 530
“Several studies have provided strong evidence that genomic DNA damage leads to neuroinflammation, which can promote cellular senescence, and recent findings suggest that cell senescence occurs in glial cells in AD (40).”
BackgroundSex differences in cancer mechanisms
Rubin, J. B., Lagas, J. S., Broestl, L., Sponagel, J., Rockwell, N., Rhee, G., Rosen, S. F., Chen, S., Klein, R. S., Imoukhuede, P., et al. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00291-x · Cited by 366
TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease
Yang, J., Wise, L., & Fukuchi, K.-I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00724 · Cited by 387
“IL-1β, IL-6, TGF-β, and TNF-α levels are elevated in AD brain tissue, as well as in AD patients’ CSF and serum (143).”
BackgroundOrr, M., Gonzales, M., Garbarino, V., Kautz, T., Palavicini, J., Lopez-Cruzan, M., Dehkordi, S. K., Mathews, J., Zare, H., Xu, P., et al. (2023) · doi:10.21203/rs.3.rs-2809973/v1 · Cited by 319
Cellular senescence in brain aging
Sikora, E., Bielak-Zmijewska, A., Dudkowska, M., Krzystyniak, A., Mosieniak, G., Wesierska, M., & Wlodarczyk, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.646924 · Cited by 304
“As the hallmarks of cell senescence encompass more than just irreversible growth arrest, the studies to identify markers of neuronal senescence, that is senescence of proliferationincompetent cells, were recently performed both in vivo and in vitro (Tan et al., 2014; Kritsilis et al., 2018; Wengerodt et al., 2019).”
BackgroundTherapy-Induced Senescence: An “Old” Friend Becomes the Enemy
Saleh, T., Bloukh, S., Carpenter, V. J., Alwohoush, E., Bakeer, J., Darwish, S., Azab, B., & Gewirtz, D. A. (2020) · Cancers · doi:10.3390/cancers12040822 · Cited by 290
Cellular Senescence in Neurodegenerative Diseases
Martínez-Cué, C., & Rueda, N. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00016 · Cited by 281
Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial
Gonzales, M. M., Garbarino, V. R., Kautz, T. F., Palavicini, J. P., Lopez-Cruzan, M., Dehkordi, S. K., Mathews, J. J., Zare, H., Xu, P., Zhang, B., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02543-w · Cited by 334
“Secondary trial aims were as follows: (1) to examine baseline to post-treatment changes in cognition and functional status; (2) to assess changes in neuroimaging and biofluid markers of AD and related dementias (ADRD) and (3) to evaluate target engagement of D + Q by examining changes markers associated with cellular…”
BackgroundInfluentialMitochondrial phosphatase PGAM5 modulates cellular senescence by regulating mitochondrial dynamics
Yu, B., Ma, J., Li, J., Wang, D., Wang, Z., & Wang, S. (2020) · Nature Communications · doi:10.1038/s41467-020-16312-7 · Cited by 261
Hussain, B., Fang, C., & Chang, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.688090 · Cited by 255
The Ageing Brain: Molecular and Cellular Basis of Neurodegeneration
Azam, S., Haque, M. E., Balakrishnan, R., Kim, I.-S., & Choi, D.-K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.683459 · Cited by 255
“SASP is a survival process for healthy cells, facilitating the removal of damaged cells under stressful conditions (Kültz, 2005).”
BackgroundTherapeutic Properties and Pharmacological Activities of Asiaticoside and Madecassoside: A Review
Bandopadhyay, S., Mandal, S., Ghorai, M., Jha, N. K., Kumar, M., Radha, Ghosh, A., Proćków, J., Pérez de la Lastra, J. M., & Dey, A. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17635 · Cited by 220
Spermidine and spermine delay brain aging by inducing autophagy in SAMP8 mice
Xu, T.-T., Li, H., Dai, Z., Lau, G. K., Li, B.-Y., Zhu, W.-L., Liu, X.-Q., Liu, H.-F., Cai, W.-W., Huang, S.-Q., et al. (2020) · Aging · doi:10.18632/aging.103035 · Cited by 200
Gonzales, M. M., Garbarino, V. R., Marques Zilli, E., Petersen, R. C., Kirkland, J. L., Tchkonia, T., Musi, N., Seshadri, S., Craft, S., & Orr, M. E. (2022) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2021.62 · Cited by 203
Algorithmic assessment of cellular senescence in experimental and clinical specimens
Kohli, J., Wang, B., Brandenburg, S. M., Basisty, N., Evangelou, K., Varela-Eirin, M., Campisi, J., Schilling, B., Gorgoulis, V., & Demaria, M. (2021) · Nature Protocols · doi:10.1038/s41596-021-00505-5 · Cited by 196
Self-citationImmune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases
Song, P., An, J., & Zou, M.-H. (2020) · Cells · doi:10.3390/cells9030671 · Cited by 198
“Senescence of the central nervous system (CNS) drives many neurodegenerative diseases [55], including Alzheimer’s disease (AD), Parkinson’s disease (PD) and other types of dementia (Table 1).”
BackgroundAstrocyte Senescence and Alzheimer’s Disease: A Review
Han, X., Zhang, T., Liu, H., Mi, Y., & Gou, X. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00148 · Cited by 177
Age-related immune alterations and cerebrovascular inflammation
Finger, C. E., Moreno-Gonzalez, I., Gutierrez, A., Moruno-Manchon, J. F., & McCullough, L. D. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01361-1 · Cited by 173
“The hippocampus and the striatum of patients with neurodegenerative disorders show high levels of pro-inflammatory cytokines associated with senescence [197].”
Song, Y.-J., Li, S.-R., Li, X.-W., Chen, X., Wei, Z.-X., Liu, Q.-S., & Cheng, Y. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00157 · Cited by 167
“Neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), are characterized by the sustained cell cycle arrest and production of a continuous senescence-associated secretory phenotype due to structural and functional changes in neurons (Kritsilis et al., 2018).”
BackgroundSmall molecules as therapeutic drugs for Alzheimer's disease
Oliver, D. M. A., & Reddy, P. H. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.03.001 · Cited by 156
CD38 in Neurodegeneration and Neuroinflammation
Guerreiro, S., Privat, A.-L., Bressac, L., & Toulorge, D. (2020) · Cells · doi:10.3390/cells9020471 · Cited by 141
“Of note, brain tissues from multiple sclerosis, Alzheimer’s disease, and amyotrophic lateral sclerosis patients showed increased numbers of senescent cells, mostly astrocytes [70,71].”
BackgroundDerry, P. J., Hegde, M. L., Jackson, G. R., Kayed, R., Tour, J. M., Tsai, A.-L., & Kent, T. A. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101716 · Cited by 140
“In the brain, recent work suggests that the pathological deposition of tau is associated with cellular senescence and may contribute to many features of neurodegeneration including cognitive decline and brain atrophy (Kritsilis et al., 2018; Musi et al., 2018).”
BackgroundClarke, J.-P. W. E., Thibault, P. A., Salapa, H. E., & Levin, M. C. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.659610 · Cited by 149
Jin, S., Zhang, L., & Wang, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115215 · Cited by 158
Targeting senescent cells: approaches, opportunities, challenges
von Kobbe, C. (2019) · Aging · doi:10.18632/aging.102557 · Cited by 127
“Neurodegenerative disorders Senescent cell accumulation has been detected at sites of brain pathology [7, 32, 33].”
BackgroundFard, M. T., & Stough, C. K. K. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00056 · Cited by 132
de Mera-Rodríguez, J. A., Álvarez-Hernán, G., Gañán, Y., Martín-Partido, G., Rodríguez-León, J., & Francisco-Morcillo, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.623175 · Cited by 123
Jiang, S.-Y., Tian, T., Yao, H., Xia, X.-M., Wang, C., Cao, L., Hu, G., Du, R.-H., & Lu, M. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-023-01216-y · Cited by 123
“During aging process in the brain, senescence is observed in both glia cells and post-mitotic neurons, which plays a detrimental role in age-associated neurodegenerative disorders progression [5, 6].”
BackgroundMolecular Basis of Alzheimer’s Disease: Focus on Mitochondria
Oliver, D. M. A., & Reddy, P. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190048 · Cited by 120
Yang, B., Dan, X., Hou, Y., Lee, J., Wechter, N., Krishnamurthy, S., Kimura, R., Babbar, M., Demarest, T., McDevitt, R., et al. (2021) · Aging Cell · doi:10.1111/acel.13329 · Cited by 108
“Senescent cells accumulate in the nervous system with aging and in neurodegenerative diseases and may predate the appearance of neurodegeneration or aggravate its course (Kritsilis et al., 2018).”
BackgroundOligomeric Aβ in the monkey brain impacts synaptic integrity and induces accelerated cortical aging
Beckman, D., Ott, S., Donis-Cox, K., Janssen, W. G., Bliss-Moreau, E., Rudebeck, P. H., Baxter, M. G., & Morrison, J. H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902301116 · Cited by 111
“In elderly people, systemic inflammatory diseases can lead to a chronic lowgrade inflammatory state in the brain that affects glial cells, including microglia and astrocytes, that are often the first responders to stressful events in the brain (25).”
BackgroundThe role of natural killer cells in Parkinson’s disease
Earls, R. H., & Lee, J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00505-7 · Cited by 98
Immunosenescence in multiple sclerosis: the identification of new therapeutic targets
Dema, M. G., Eixarch, H., Villar, L. M., Montalbán, X., & Espejo, C. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102893 · Cited by 107
“Indeed, senescent neurons and glial cells also accumulate in the nervous system with age, predisposing individuals to the appearance and aggravation of neurodegenerative events [100].”
BackgroundReview of the anti-inflammatory effect of SIRT1 and SIRT2 modulators on neurodegenerative diseases
Zhang, Y., Anoopkumar‐Dukie, S., Arora, D. S., & Davey, A. K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172847 · Cited by 99
The role of senescent T cells in immunopathology
Covre, L. P., De Maeyer, R. P. H., Gomes, D. C. O., & Akbar, A. N. (2020) · Aging Cell · doi:10.1111/acel.13272 · Cited by 93
“…age leads to organ dysfunction, driving inflammation and may underlie many age-related diseases such as atherosclerosis (Childs et al., 2016), osteoarthritis (Jeon et al., 2017), neurodegenerative diseases (Chinta et al., 2018; Kritsilis et al., 2018) and cirrhosis (Wiemann et al., 2002).”
BackgroundGlucose metabolism, neural cell senescence and Alzheimer's disease
Wang, Q., Duan, L., Li, X., Wang, Y., Guo, W., Guan, F., & Ma, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084351 · Cited by 90
“The conventional concept holds that senescence is a unique feature of replicating cells [28].”
BackgroundVaresi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Wang, S., Wang, X., Cheng, Y., Ouyang, W., Sang, X., Liu, J., Su, Y., Liu, Y., Li, C., Yang, L., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3632169 · Cited by 96
“However, SNC clearance methods are not universal and depend on the types of cells and diseases, which complicates the treatment prospects [67].”
BackgroundBehaviour Hallmarks in Alzheimer’s Disease 5xFAD Mouse Model
Pádua, M. S., Guil‐Guerrero, J. L., & Lopes, P. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126766 · Cited by 97
“Human ageing is the progressive accumulation of changes with time that are associated with or responsible for the ever-increasing susceptibility to many metabolic disorders, including among others, the neurodegenerative diseases, such as Alzheimer’s [1–3].”
BackgroundRe-thinking the Etiological Framework of Neurodegeneration
Castillo, X., Castro-Obregón, S., Gutiérrez-Becker, B., Gutiérrez-Ospina, G., Karalis, N., Khalil, A. A., Lopez-Noguerola, J. S., Rodríguez, L. L., Martínez-Martínez, E., Perez-Cruz, C., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00728 · Cited by 79
Preininger, M. K., & Kaufer, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116217 · Cited by 92
Reactive gliosis in traumatic brain injury: a comprehensive review
Amlerova, Z., Chmelová, M., Anděrová, M., & Vargová, L. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1335849 · Cited by 93
Aging, Cellular Senescence, and Progressive Multiple Sclerosis
Papadopoulos, D., Magliozzi, R., Mitsikostas, D. D., Gorgoulis, V. G., & Nicholas, R. S. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00178 · Cited by 79
“We have previously provided evidence of senescent glial cells and neurons showing lipofuscin senescent glial cells in acute and chronic actively demyelinated white matter lesions from SPMS cases using GL13 histochemistry (Kritsilis et al., 2018).”
BackgroundSelf-citationThe role of sirtuin 1 in ageing and neurodegenerative disease: A molecular perspective
Thapa, R., Moglad, E. H. O., Afzal, M., Gupta, G., Bhat, A. A., Almalki, W. H., Kazmi, I. A., Alzarea, S. I., Pant, K., Singh, T. G., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102545 · Cited by 97
Jurcău, M. C., Jurcău, A., Cristian, A., Hogea, V. O., Diaconu, R. G., & Nunkoo, V. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910535 · Cited by 104
“…cancer-related gene 4 (Ecrg4), with increased expression in aged mouse brains, may cause them to enter a senescence-like state with an increased expression of SA-β -Gal and failure in their essential function of mediating remyelination via differentiation into myelinating oligodendrocytes [26].”
BackgroundRemembering your A, B, C's: Alzheimer's disease and ABCA1
Lewandowski, C. T., Laham, M. S., & Thatcher, G. R. J. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.01.011 · Cited by 76
Cellular senescence in the aging brain: A promising target for neurodegenerative diseases
Sahu, M. R., Rani, L., Subba, R., & Mondal, A. C. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111675 · Cited by 75
Psenicka, M. W., Smith, B. C., Tinkey, R. A., & Williams, J. L. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.654284 · Cited by 75
Senescence and impaired DNA damage responses in alpha-synucleinopathy models
Yoon, Y.-S., You, J. S., Kim, T.-K., Ahn, W. J., Kim, M. J., Son, K. H., Ricarte, D., Ortiz, D. M., Lee, S., & Lee, H.-J. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00727-x · Cited by 68
Wang, M., Tian, T., Zhou, H., Jiang, S., Jiao, Y., Zhu, Z., Xia, J., Ma, J., & Du, R. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03072-0 · Cited by 82
“Senescent astrocytes show large morphology and exhibit enhanced senescence marker p16 expression, elevated senescence-associated β-galactosidase (SA-β-Gal) activity, and increased senescence-associated secretory phenotype (SASP) secretion [4–6].”
BackgroundChen, H., Zhou, Y., Huang, L., Xu, X., & Yuan, C. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12840 · Cited by 74
“55) into the samemodel; (6) we used the Fine&Gray’smodel treatingmortality as the competing event; (7) we further excluded participants who reported dementia diagnosis within 2 years after baseline; and 8) we further adjusted the models for baseline cognitive function and APOE ε4 allele status (0, “no E4”; 1, “one E4”…”
MethodGupta, R. V., Sahu, M., Tripathi, R. S., Ambasta, R. K., & Kumar, P. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101579 · Cited by 72
Chen, S., Chen, L., Qi, Y., Xu, J., Ge, Q., Fan, Y., Chen, D., Zhang, Y., Wang, L., Hou, T., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00129-0 · Cited by 72
Cellular senescence in Alzheimer’s disease: from physiology to pathology
Zhu, J., Wu, C., & Yang, L. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00447-4 · Cited by 77
Akhtar, A., Rad, V. F., Moradi, A., Yar, M., & Bazzar, M. (2022) · Smart Materials in Medicine · doi:10.1016/j.smaim.2022.11.007 · Cited by 70
Martin-Ruiz, C., Williams-Gray, C. H., Yarnall, A. J., Boucher, J. J., Lawson, R. A., Wijeyekoon, R. S., Barker, R. A., Kolenda, C., Parker, C., Burn, D. J., et al. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191724 · Cited by 58
“senescence suggested their relevance as biomarkers 544 of ageing [37, 58].”
BackgroundShared mechanisms for cognitive impairment and physical frailty: A model for complex systems
Sargent, L. J., Nalls, M. A., Amella, E. J., Slattum, P. W., Mueller, M., Bandinelli, S., Tian, Q., Swift‐Scanlan, T., Lageman, S. K., & Singleton, A. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12027 · Cited by 65
Sah, E., Krishnamurthy, S., Ahmidouch, M. Y., Gillispie, G. J., Milligan, C., & Orr, M. E. (2021) · Life · doi:10.3390/life11030229 · Cited by 55
“manifest as an increase in neuroinflammation, increased BBB permeability, loss of neuronal synapses, demyelination, and dysregulated metabolism [179,186].”
BackgroundEscape from senescence: molecular basis and therapeutic ramifications
Evangelou, K., Belogiannis, K., Papaspyropoulos, A., Petty, R., & Gorgoulis, V. G. (2023) · The Journal of Pathology · doi:10.1002/path.6164 · Cited by 62
“Neuronal tissue Human [110] HeLa cell xenograft tumours NSG mice [111] Thymus gland Human [112] Heart, kidney Wistar rats [113] Pancreatic ductal carcinomas Human [114] Skin (actinic keratosis) Human, K5-rtTA Mice [115] Lung Human [116] Various sarcomas Human [117] Neuronal tissue Human [118] Lung, liver, fatty tissue…”
BackgroundSelf-citationShang, D., Hong, Y., Xie, W., Tu, Z., & Xu, J. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00929 · Cited by 54
“Since IL-1β can induce cellular senescence, we speculated that this cytokine might also activate SASP pathways.”
BackgroundInfluentialCNS Ageing in Health and Neurodegenerative Disorders
Kesidou, E., Theotokis, P., Damianidou, O., Boziki, M. K., Konstantinidou, N., Taloumtzis, C., Sintila, S.-A., Grigoriadis, P., Evangelopoulos, M., Bakirtzis, C., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062255 · Cited by 90
Ionizing Radiation-Induced Brain Cell Aging and the Potential Underlying Molecular Mechanisms
Wang, Q., Yin, G., Huang, J., Xi, S.-J., Qian, F., Lee, R.-X., Peng, X., & Tang, F. R. (2021) · Cells · doi:10.3390/cells10123570 · Cited by 62
“Such radiation also increases the proportion of SA-β-Gal-positive cerebral vascular endothelial cells [3].”
BackgroundGenome Instability and DNA Repair in Somatic and Reproductive Aging
Panier, S., Wang, S., & Schumacher, B. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051122-093128 · Cited by 71
Alzheimer’s disease and gut microbiota: does trimethylamine N-oxide (TMAO) play a role?
Arrona Cardoza, P., Spillane, M. B., & Morales Marroquin, E. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuab022 · Cited by 53
Tau affects P53 function and cell fate during the DNA damage response
Sola, M., Magrin, C., Pedrioli, G., Pinton, S., Salvadè, A., Papin, S., & Paganetti, P. (2020) · Communications Biology · doi:10.1038/s42003-020-0975-4 · Cited by 54
Role of hydrogen sulfide in health and disease
Jin, Y., Yuan, H., Liu, Y., Zhu, Y., Wang, Y., Liang, X., Gao, W., Ren, Z., Ji, X., & Wu, D. (2024) · MedComm · doi:10.1002/mco2.661 · Cited by 54
Mouresan, E. F., Mentesidou, E., Berglund, A., McKay, K. A., Hillert, J. A., & Iacobaeus, E. (2024) · Neurology · doi:10.1212/wnl.0000000000208051 · Cited by 69
Liu, N., Lyu, X., Zhang, X., Zhang, F., Chen, Y., & Li, G. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01129-w · Cited by 62
The Post-amyloid Era in Alzheimer's Disease: Trust Your Gut Feeling
Osorio, C., Kanukuntla, T., Diaz, E., Jafri, N., Cummings, M., & Sfera, A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00143 · Cited by 49
Zhang, W., Xu, M., Chen, F., Su, Y., Yu, M., Xing, L., Chang, Y. E., & Yan, T. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114474 · Cited by 60
Kwiatkowska, K. M., Mavrogonatou, E., Papadopoulou, A., Sala, C., Calzari, L., Gentilini, D., Bacalini, M. G., Dall’Olio, D., Castellani, G., Ravaioli, F., et al. (2023) · Cells · doi:10.3390/cells12060927 · Cited by 54
“Taking together these results led us to speculate that, in consideration of the high epigenetic homogenizing effect of cellular senescence on the different cell types, such common methylation remodeling could be particularly detrimental in the cells belonging to the nervous system, in agreement with the theory that th…”
ResultThe application of nanotechnology in treatment of Alzheimer’s disease
Cao, Y., & Zhang, R. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1042986 · Cited by 59
“In addition, the development of both types of AD is caused by agerelated variables such as reactive oxygen species (ROS), malfunction in mitochondria, and phosphorylation of tau (Kritsilis et al., 2018; Reddy et al., 2018).”
BackgroundRole of Molecular Hydrogen in Ageing and Ageing‐Related Diseases
Fu, Z., Zhang, J., & Zhang, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2249749 · Cited by 57
“Ageing represents a continuous risk of chronic noncom-municable diseases, such as neurodegenerative diseases, cardiovascular diseases (CVDs), diabetes, and cancer [5], although it is not the only factor.”
Liu, Z., Fayyaz, S., Zhao, D., Yi, Z., Huang, J., Zhou, R.-R., Xie, J., Liu, P.-A., He, W. G., Zhang, S., et al. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105476 · Cited by 54
The role of the complement system in Multiple Sclerosis: A review
Saez-Calveras, N., & Stüve, O. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.970486 · Cited by 57
“In subpial cortical lesions, the neuronal soma of progressive MS patients demonstrates hallmarks of cellular senescence including the presence of cytoplasmic lipofuscin (72).”
BackgroundRetrotransposons as a Source of DNA Damage in Neurodegeneration
Pezé-Heidsieck, E., Bonnifet, T., Znaidi, R., Ravel‐Godreuil, C., Massiani-Beaudoin, O., Joshi, R. L., & Fuchs, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.786897 · Cited by 59
“…lifespan and disease: A state-of-the-art review (Sameri et al., 2020) Cellular senescence Aging, cellular senescence and neurodegenerative disease (Kritsilis et al., 2018) Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (Baker and Petersen, 2018)…”
BackgroundInfluentialAn aging-related immune landscape in the hematopoietic immune system
Lv, J., Zhang, C., Liu, X., Gu, C., Liu, Y., Gao, Y., Huang, Z., Jiang, Q., Chen, B., He, D., et al. (2024) · Immunity & Ageing · doi:10.1186/s12979-023-00403-2 · Cited by 56
“As aging progresses, the normal physiological functions of several systems, including the immune system, gradually become dysfunctional [2, 3].”
BackgroundBiomaterials-based anti-inflammatory treatment strategies for Alzheimer’s disease
Chu, J., Zhang, W., Liu, Y., Gong, B., Ji, W., Yin, T., Gao, C., Liangwen, D., Hao, M., Chen, C., et al. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.374137 · Cited by 53
Neumann, P., Lenz, D. E., Streit, W. J., & Bechmann, I. (2022) · Glia · doi:10.1002/glia.24282 · Cited by 54
“lost their ability to proliferate (Kritsilis et al., 2018).”
BackgroundMcCarthy, C. G., Wenceslau, C. F., Webb, R. C., & Joe, B. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpz052 · Cited by 50
Asghar, M., Odeh, A., Fattahi, A. J., Henriksson, A. E., Miglar, A., Khosousi, S., & Svenningsson, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-22400-z · Cited by 54
Health repercussions of environmental exposure to lead: Methylation perspective
Shiek, S. S., Mani, M. S., Kabekkodu, S. P., & Dsouza, H. S. (2021) · Toxicology · doi:10.1016/j.tox.2021.152927 · Cited by 53
DNA repair deficiency and senescence in concussed professional athletes involved in contact sports
Schwab, N., Grenier, K., & Hazrati, L.-N. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0822-3 · Cited by 47
Muwanigwa, M. N., Modamio, J., Antony, P. M. A., Gomez‐Giro, G., Krüger, R., Bolognin, S., & Schwamborn, J. C. (2024) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2024.103919 · Cited by 56
“Thus, one could speculate that the presence of senescent astrocytes in the 3xSNCA hMO may negatively impact the dopaminergic neurons via the effects of the SASP.”
Identification of distinct and age‐dependent p16High microglia subtypes
Talma, N., Gerrits, E., Wang, B., Eggen, B. J. L., & Demaria, M. (2021) · Aging Cell · doi:10.1111/acel.13450 · Cited by 46
Insights on the Use of Transgenic Mice Models in Alzheimer’s Disease Research
Pádua, M. S., Guil-Guerrero, J. L., Prates, J. A. M., & Lopes, P. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052805 · Cited by 46
Reutzel, M., Grewal, R., Dilberger, B., Silaidos, C. V., Joppe, A., & Eckert, G. P. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4060769 · Cited by 43
“The average life expectancy has increased considerably to over 80 years in developed countries [1], and the multifactorial aging process is characterized by several changes on the cellular level [2, 3].”
BackgroundSun, Y.-R., Lv, Q.-K., Liu, J., Wang, F., & Liu, C. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106791 · Cited by 53
“These pathological protein aggregates not only disrupt normal cellular functions but may also trigger inflammation and oxidative stress, further exacerbating neuronal loss(Kritsilis et al., 2018).”
Su, I., Chang, H., Wang, H.-C., & Tsai, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155459 · Cited by 48
“The most notable recent theory of AD pathogenesis is the unifying concept of the aging process as the driving role in neurodegenerative diseases and AD [56].”
BackgroundAmburana cearensis: Pharmacological and Neuroprotective Effects of Its Compounds
Silva, J. H. C. E., Ferreira, R. S., Pereira, É. P. L., Braga‐de‐Souza, S., de Almeida, M. M. A., dos Santos, C. C., Butt, A. M., Caiazzo, E., Capasso, R., da Silva, V. D. A., et al. (2020) · Molecules · doi:10.3390/molecules25153394 · Cited by 49
“6 million people worldwide were living with dementia (with AD accounting for 60–70%) and that this number would double by 2030 and triple in 2050, bringing more social and economic impacts than cancer [39,40].”
BackgroundCircular RNAs : emerging players in brain aging and neurodegenerative diseases
Wu, D., Zhao, Y., Yan, Q., Liu, L., Wei, Y., & Huang, J. (2022) · The Journal of Pathology · doi:10.1002/path.6021 · Cited by 44
Cellular senescence in cancer: molecular mechanisms and therapeutic targets
Jin, P., Duan, X., Li, L., Zhou, P., Zou, C., & Xie, K. (2024) · MedComm · doi:10.1002/mco2.542 · Cited by 57
Systemic aging and aging‐related diseases
Li, Q., Xiao, N., Zhang, H., Liang, G., Lin, Y., Qian, Z., Yang, X. Y., Yang, J., Fu, Y., Zhang, C., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202402479rrr · Cited by 59
“27 Sirt1, 2, 3, 4, 5, and 6 are major factors involved in aging regulation.”
Cellular mechanisms in brain aging: Focus on physiological and pathological aging
Aguilar‐Hernández, L., Alejandre‐Aguilar, R., Morales‐Medina, J. C., Iannitti, T., & Flores, G. (2022) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2022.102210 · Cited by 47
Zheng, L., He, S., Wang, H., Li, J., Liu, Y., & Liu, S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0206 · Cited by 81
“Upregulation of p38MAPK, a well-known SASP regulator, and an increase in SASP factors such as the pro-inflammatory cytokines IL-6, IL-1β, TGF-β, and TNF-α, as well as the extracellular proteases MMP-1, MMP-3, and MMP-10, were observed in AD brains [100-104].”
A guide to senolytic intervention in neurodegenerative disease
Lee, S., Wang, E. Y., Steinberg, A. B., Walton, C. C., Chinta, S. J., & Andersen, J. K. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111585 · Cited by 39
Cellular Senescence as the Key Intermediate in Tau-Mediated Neurodegeneration
Mendelsohn, A. R., & Larrick, J. W. (2018) · Rejuvenation Research · doi:10.1089/rej.2018.2155 · Cited by 37
“18 Senescence can be defined as a set of overlapping, inter-acting cell states characterized by irreversible cell cycle withdrawal, SASP, DNA damage, senescence-associated beta galactosidase (SA-B-Gal), expression of cell cycle inhibitory proteins, especially p16ink4a, senescence-associated…”
Tricarboxylic Acid Cycle Intermediates and Individual Ageing
Kurhaluk, N. (2024) · Biomolecules · doi:10.3390/biom14030260 · Cited by 36
“…being investigated The causes of ageing are associated with the impaired nutrient sensitivity of cellular functions, inducing cellular ageing accompanied by chronic inflammation and loss of tissue process that has a key role in driving ageing [34–36], and altered intercellular communication [37].”
BackgroundSenescence-mediated anticancer effects of quercetin
Özsoy, S., Becer, E., & Vatansever, H. S. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.04.007 · Cited by 45
Metadata
- Authors
- Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Laboratory of Histology & Embryology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, Goudi, 115-27 Athens, Greece
- Corresponding author
- Gorgoulis, Vassilis G.
- Papadopoulos, Dimitrios
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-09-27
- Volume
- 19
- Issue
- 10
- Pages
- 2937
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6213570
- OpenAlex
- W2892390537
- Cited by
- 448
- References
- 385
- Citations by year
- 2026: 46 · 2025: 63 · 2024: 90 · 2023: 63 · 2022: 57 · 2021: 58 · 2020: 47 · 2019: 23 · 2018: 1
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Multiple Sclerosis Society (207495)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- cellular senescence, aging, neurodegenerative diseases, senescence markers, lipofuscin, neurons, glial cells, Alzheimer's disease, Parkinson's disease, multiple sclerosis, senolytics, age-related diseases
- MeSH terms
- Aging, Animals, Humans, Cellular Senescence, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.